Programmatic Preparations and challenges for OCV introduction in India

Cholera mainly affects the marginalized with inequitable access to care, potable water and improved sanitation. An estimated 411 million people in India are at risk from cholera, with 675,188 cases and 20,256 deaths occurring annually. Given the global elimination plan for cholera by 2030, a multi-s...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2020-02, Vol.38, p.A175-A177
Main Author: Haldar, Pradeep
Format: Article
Language:English
Subjects:
Administration, Oral
Age groups
Cholera
Cholera - epidemiology
Cholera - prevention & control
Cholera vaccine
Cholera Vaccines - administration & dosage
Cold
Cost analysis
Decision making
Disease
Displaced persons
Drinking water
Drug delivery systems
Humans
Immunization
Immunization Programs - organization & administration
India - epidemiology
Laboratories
Pneumonia
Poliomyelitis
Production capacity
Public health
Sanitation
Schedules
Shortage of vaccines
Strategy
Use in endemic countries
Vaccination
Vaccines
Vibrio cholerae
Viruses
Waterborne diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cholera mainly affects the marginalized with inequitable access to care, potable water and improved sanitation. An estimated 411 million people in India are at risk from cholera, with 675,188 cases and 20,256 deaths occurring annually. Given the global elimination plan for cholera by 2030, a multi-stakeholder strategy is required. The National Technical Advisory Group on Immunization (NTAGI) Working Group on Cholera met in 2016 to review the evidence for cholera burden in India and successful oral cholera vaccine (OCV) implementation in other countries. Based on NTAGI’s recommendations, the Ministry of Health and Family Welfare will implement cholera control measures and decide on OCV’s addition to India’s Universal Immunization Programme (UIP). Key steps for OCV introduction will include choosing the vaccine formulation, developing vaccine delivery strategy, ensuring sufficient resources, engaging OCV manufacturers to ensure a sustainable supply, and developing a post-introduction evaluation strategy.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2019.06.047